Researchers say about three-quarters of gastric cancer cases worldwide are caused by the common bacteria Helicobacter pylori ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with chemotherapy, according to interim data from a late-stage study.

Did you know that stomach cancer makes up around 1.5% of all new cancer cases diagnosed annually in the US? Globally, over ...

Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

Of all early-onset cancers in the U.S., gastrointestinal cancers are increasing most rapidly, according to a review published July 17 in JAMA.  Defined as occurring in patients under the age of 50, ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Treatment for stomach cancer often involves a combination of surgery, chemotherapy, targeted therapy, immunotherapy, radiation, and palliative care. Read on.

Find all the latest on gastric cancer at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.

This comprehensive review highlights the compositional and functional heterogeneity of intratumoral microbiota within the ...

Data from population-based studies have shown an increased incidence of certain types of neoplasms in patients younger than 50 years (early-onset cancer [EOC]); however, little information is derived ...

Intratumoral microbiota-the microbial populations residing within solid tumors-have emerged as pivotal components of the tumor microenvironment (TME), influencing tumor initiation, progression, and ...